Nuno Costa-Borges

Dr. Nuno Costa-Borges


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Cellular Reprogramming
Verified
Journal Article
Closed access
NCNuno Costa-Borges
Nuno Costa-Borges
JSJosep Santaló
Josep Santaló
EIElena Ibáñez
Elena Ibáñez
Reprogramming of differentiated nuclei into a totipotent embryonic state following somatic cell nuclear transfer (SCNT) is not efficient. Previous studies in the hybrid B6D2F1 mouse strain revealed that a transient treatment of the SCNT embryos with the histone deacetylase inhibitor (HDACi) trichostatin A (TSA) significantly enhance the potential of the cloned embryos to develop in vitro and to term. Here, we compare two different SCNT protocols with TSA and explore, for the first time, the effect of another HDACi, valproic acid (VPA), on the in vitro development, blastocyst quality, and full-term development of mouse B6CBAF1 cloned embryos. Rates of blastocyst development in SCNT embryos treated with either 5 nM TSA during and after activation (31.8%) or with 100 nM TSA or 2 mM VPA before and during activation (34.5 and 38.3%, respectively) were clearly superior to those of nontreated SCNT embryos (22.9-25.1%). These increased in vitro development rates of the HDACi-treated embryos were correlated with an increased level of histone H3 lysine 14 acetylation and an improved blastocyst quality, as judged by the increased number of total and ICM cells in comparison to the nontreated embryos (30-35% increase). Treatment of SCNT embryos with TSA or VPA also allowed the obtention of viable cloned mice, whereas none could be produced from untreated SCNT embryos. In conclusion, we have demonstrated for the first time that VPA can improve the in vitro and full-term development of B6CBAF1 SCNT embryos, at a similar level as TSA. Our findings may open new opportunities to improve cloning efficiencies in other mouse strains or species.

1 March 2016 in Fertility and Sterility
Verified
Journal Article
Closed access
NCNuno Costa-Borges
Nuno Costa-Borges
MBMarta Bellés
Marta Bellés
MMMarcos Meseguer
Marcos Meseguer
DGDaniela Galliano
Daniela Galliano
ABAgustin Ballesteros
Agustin Ballesteros
GCGloria Calderón
Gloria Calderón

29 April 2020 in eLife
Verified
Journal Article
Open access
NCNuno Costa-Borges
Nuno Costa-Borges
KSKatharina Spath
Katharina Spath
IMIrene Miguel-Escalada
Irene Miguel-Escalada
EMEnric Mestres
Enric Mestres
RBRosa Balmaseda
Rosa Balmaseda
GCGloria Calderón
Gloria Calderón
The developmental potential of early embryos is mainly dictated by the quality of the oocyte. Here, we explore the utility of the maternal spindle transfer (MST) technique as a reproductive approach to enhance oocyte developmental competence. Our proof-of-concept experiments show that replacement of the entire cytoplasm of oocytes from a sensitive mouse strain overcomes massive embryo developmental arrest characteristic of non-manipulated oocytes. Genetic analysis confirmed minimal carryover of mtDNA following MST. Resulting mice showed low heteroplasmy levels in multiple organs at adult age, normal histology and fertility. Mice were followed for five generations (F5), revealing that heteroplasmy was reduced in F2 mice and was undetectable in the subsequent generations. This pre-clinical model demonstrates the high efficiency and potential of the MST technique, not only to prevent the transmission of mtDNA mutations, but also as a new potential treatment for patients with certain forms of infertility refractory to current clinical strategies.

17 January 2021 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
EME Mestres
E Mestres
MGM García-Jiménez
M García-Jiménez
ACA Casals
A Casals
JCJ Cohen
J Cohen
MAM Acacio
M Acacio
NCNuno Costa-Borges
Nuno Costa-Borges
STUDY QUESTION: Which lab-related factors impact the culture system’s capacity to maintain a stable osmolality during human embryo culture?SUMMARY ANSWER: Incubator humidity, the volume of mineral oil, the type of culture media and the design of time-lapse dishes have been identified as important parameters that can cause an impact on media evaporation and consequently osmolality during culture.WHAT IS KNOWN ALREADY: Culture medium is a critical component in human embryo culture. Minimizing its evaporation during culture is an adequate strategy to stabilize osmolality and, as a result, improving culture conditions and clinical outcomes.STUDY DESIGN, SIZE, DURATION: The studied variables included media composition and supplementation; volume of mineral oil; incubator humidification; and the type of dish and incubator used. Additionally, six time-lapse dish models were compared in their ability to prevent evaporation.PARTICIPANTS/MATERIALS, SETTING, METHODS: Dishes were incubated in parallel to analyze osmolality during culture between groups: synthetic oviductal medium enriched with potassium versus human tubal fluid medium; protein versus no protein supplementation; dry versus humid atmosphere; high versus low volume of mineral oil. Additionally, media evaporation was compared between six models of time-lapse dishes with distinct designs, cultured in a joint incubator. Two of them were retested in their corresponding incubator to analyze the dish-incubator fit. Daily osmolality measurements were compared between groups. Linear regression was performed to analyze evaporation rates.MAIN RESULTS AND THE ROLE OF CHANCE: Protein supplementation did not significantly affect evaporation. Contrarily, humidity levels inside the incubators, the volume of mineral oil and the type of culture media, played an important role in osmolality stabilization. The design of time-lapse dishes and their recommended preparation protocol heavily influenced their evaporation rates, which were further altered by each incubator’s characteristics. Media with initially high osmolalities had a bigger risk of reaching hypertonic levels during culture.LIMITATIONS, REASONS FOR CAUTION: While numerous, the studied variables are limited and therefore other factors could play a role in osmolality dynamics, as well. Incontrollable atmospheric factors could also result in some variation in the observed results between different centers and laboratories.WIDER IMPLICATIONS OF THE FINDINGS: Published literature has extensively described how hypertonic media may impair embryo development and negatively affect clinical outcomes; therefore, maintaining a stable osmolality during culture should be considered essential. This work is of interest both for embryologists when analyzing their culture system and methodologies, as well as manufacturers in charge of designing IVF consumables.STUDY FUNDING/COMPETING INTEREST(S): This study was privately funded.TRIAL REGISTRATION NUMBER: N/A.

13 November 2021 in Human Reproduction
Verified
Journal Article
Closed access
EME Mestres
E Mestres
QMQ Matia-Algué
Q Matia-Algué
AVA Villamar
A Villamar
ACA Casals
A Casals
MAM Acacio
M Acacio
NCNuno Costa-Borges
Nuno Costa-Borges
STUDY QUESTION: Are there significant differences between the available commercial oil brands used for human IVF?SUMMARY ANSWER: Important differences have been detected among the tested oil brands in their potential to stabilize culture conditions and, more importantly, in their direct effect on embryo development and viability.WHAT IS KNOWN ALREADY: Mineral oil is a critical component of the human culture system due to its protective and stabilizing roles during in vitro embryo development. Many different oils are available on the market, with differences in their viscosity, density and overall quality.STUDY DESIGN, SIZE, DURATION: Thirteen different commercial oil brands were compared.PARTICIPANTS/MATERIALS, SETTING, METHODS: Each oil was firstly analyzed to assess its viscosity, density, peroxide value and potential oxidation. Secondly, the capacity of each oil to reduce pH, osmolality and temperature fluctuations during embryo culture and manipulation was compared. Lastly, a sensitive mouse embryo assay (MEA) protocol, previously optimized to detect toxicity in oils samples, was used to compare the overall quality of the different brands in terms of embryo developmental rates up to the blastocyst stage. At the end of the MEAs, a triple labeling protocol was applied to analyze Oct4+ cells, apoptotic cells and total cell counts in the blastocysts obtained by fluorescence microscopy.MAIN RESULTS AND THE ROLE OF CHANCE: Significant divergences were detected in the rise of osmolality and the equilibration and stability of pH between different oils, which could be correlated to their physico-chemical characteristics. In particular, oil samples with a higher viscosity tended to offer an additional protection against fluctuations in the culture conditions, however, the differences in temperature stability between oils were minor. Two out of the 13 oil samples, which were commercially available, were identified as embryo-toxic by applying the MEA protocol with increased sensitivity for toxicity detection. Additionally, substantial differences in the total number of cells and the number of cells in the inner cell mass of the obtained blastocysts were also detected between oil groups.LIMITATIONS, REASONS FOR CAUTION: A single lot of oil was used for each brand and, thus, lot-to-lot variations in oil quality could not be determined. However, several bottles from the same oil were included to account for potential intra-lot variability.WIDER IMPLICATIONS OF THE FINDINGS: Commercial oils differ in both their physical characteristics and their performance in maintaining the stability of the culture conditions during in vitro embryo culture. Oil selection is important for embryo culture success. Additionally, the detection of embryo-toxic oils which had already been released to the human IVF market showcases the importance of applying sensitive MEA protocols for a better detection of toxicity in this type of samples.STUDY FUNDING/COMPETING INTEREST(S): This study was privately funded.TRIAL REGISTRATION NUMBER: N/A.

7 May 2025 in Human Reproduction
Verified
Journal Article
Closed access
NCNuno Costa-Borges
Nuno Costa-Borges
QMQueralt Matia-Algué
Queralt Matia-Algué
ACAila Coello
Aila Coello
EMEnric Mestres
Enric Mestres
MAMònica Acacio
Mònica Acacio
JCJacques Cohen
Jacques Cohen
STUDY QUESTION: Can fast vitrification (FV) and fast warming (FW) protocols effectively reduce oocyte exposure times to cryoprotectants while maintaining survival, developmental potential, and laboratory efficiency compared to a standard protocol? SUMMARY ANSWER: FV and FW protocols significantly reduce exposure times compared to a standard protocol without compromising oocyte integrity or developmental potential in the animal models tested, offering a more efficient workflow for IVF laboratories. WHAT IS KNOWN ALREADY: Vitrification is a widely used oocyte cryopreservation technique in IVF centers, but current protocols are time-consuming and labor-intensive. Additionally, prolonged exposure to cryoprotectants under non-physiological conditions, such as high osmolality and room temperature, raises concerns about oocyte viability and developmental potential. STUDY DESIGN, SIZE, DURATION: This preclinical study involved oocytes from two animal models (mouse and rabbit) and a subset of discarded human oocytes. Experimental stages included: (a) evaluation of meiotic spindle integrity; (b) assessment of survival and developmental rates post-warming and ICSI; (c) embryo transfers in mice to evaluate full-term developmental potential; and (d) development and validation of an in silico model for human oocytes. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mouse and rabbit oocytes were randomly allocated to either a fast or standard vitrification (SV)/standard warming (SW) protocol. Survival and developmental rates were assessed post-warming. Meiotic spindle integrity and chromosomal alignment were analyzed using immunofluorescence. Full-term development was evaluated through embryo transfers in mice. Theoretical osmotic modeling was performed on human oocytes to predict their behavior under FV conditions, with empirical validation using discarded human oocytes. MAIN RESULTS AND THE ROLE OF CHANCE: The FV/FW protocol significantly reduced the time required for vitrification compared to a SV/SW protocol, while maintaining comparable oocyte survival, meiotic spindle integrity, and developmental rates in animal models. In mouse oocytes, the FV/FW protocol achieved the highest survival rate (n = 249 oocytes; 97.2%) not statistically significantly different from the SV/SW protocol (n = 224 oocytes, 94.2%), but significantly higher (P = 0.008) than the SV/FW group (n = 229 oocytes, 91.7%). After ICSI, the SV/SW group reached 83.4% blastocyst rates, followed by the FV/FW group at 80.9%, and the SV/FW group at 75.9%, all comparable to the fresh oocyte control group (n = 123) with 86.4%. Embryo development after ICSI resulted in blastocyst formation rates of 80.9% for the FV/FW protocol compared to 83.4% in the SV/SW and 86.4% in the SV/FW group. Embryo transfer outcomes in mice demonstrated no statistically significant adverse effects on implantation or full-term development, with live birth rates of 38.7% (FV/FW) compared to 47.8% (SV/SW) and 43.2% (SV/FW). Survival rates of rabbit metaphase II oocytes ranged between 90% and 100% across all protocols, while blastocyst developmental rates were higher in the FV/FW group (28.6%) compared to the SV/SW group (22.2%) and the SV/FW group (13.6%). The mathematical in silico osmotic model predicted favorable responses for human oocytes, which were confirmed experimentally in discarded human oocytes with survival rates of 94.1% (n = 101) for the SV/FW protocol and 97.1% (n = 103) for the FV/FW protocol. LARGE SCALE DATA: NA LIMITATIONS, REASONS FOR CAUTION: This study was preclinical and involved animal models and discarded human oocytes. Further clinical trials are required to confirm the safety and efficacy of FV protocols in routine IVF clinical practice. WIDER IMPLICATIONS OF THE FINDINGS: FV and FW protocols offer a promising alternative to conventional methods, enhancing laboratory workflow efficiency and reducing oocyte exposure to potentially harmful cryoprotectants. These findings lay the foundation for translational research and future clinical applications in clinical IVF settings. STUDY FUNDING/COMPETING INTEREST(S): This study was privately funded by Conceivable Life Sciences and Embryotools S.L. N.C.-B. reports stock with Embryotools and stock options with Conceivable Life Sciences and Fertility. N.C.-B. is also salaried by Embryotools. A.C.-B. received support for attending meetings from Conceivable Life Sciences and holds patents and stock with Conceivable Life Sciences, and stock with Hope IVF Mexico and IVF 2.0. A.F.-S.F. has received travel support from Conceivable Life Sciences and has patents with them as well as stock options. A.C. is salaried by IVIRMA. J.C. is salaried by Conceivable Life Sciences, holds stock options with Conceivable Life Sciences, IVF 2.0 and Athea Science and has other financial/non-financial interests with Reproduction Healthcare and TMRW Life Science. TRIAL REGISTRATION NUMBER: NA